Trained Innate Immunity: Mechanisms & Meanings
How HERV-K102 Particle Production is Essential to Recovery from Cancer & Pandemics
Image 1. The M1-like Foamy Macrophages of Trained Innate Immunity That Produce the HERV-K102 Protector Foamy Retrovirus Particles.
I have pulled together a comprehensive overview of what is known about trained (innate) immunity that happens in the M1-like foamy macrophages in the attached article below. Many people are not aware of heterologous protection against tumors, viruses and yes, even chronic diseases and how this works.
For a comprehensive overview of the HERV-K102 protector system against COVID-19 disease, please see:
Published as a chapter in a medical book:
Laderoute MP. Chapter 17. Controversies Concerning the Immunology of the COVID-19 Adaptive Immunity Vaccines. In: Controversies in the Pandemic. Ed(s); J Varon, PE Marik, M Rendell, J Iglesias, C de Souza, P Prabhudesai. Jaypee Brothers Medical Publishers Ltd, New Delhi, India, 2024, pp 760. ISBN: 978-93-5696-730-4.
But also available for free downloading here:
Laderoute, M. Antibody Dependent Enhancement (ADE) of Infection into Macrophages Validates the Importance of HERV-K102 Particle Production for Pandemic Preparedness. Preprints 2023, 2023120185. https://www.preprints.org/manuscript/202312.0185/v2.DOI: 10.20944/preprints202312.0185.v2.
For those who think glycolysis is an abnormal aspect of dysfunctional mitochondria (and potentially the cause of cancer), I welcome readers to have a look at page 8 in this article.
For those who feel adaptive immunity can be exploited to cure cancer such as suggested by Larry Ellison (the CEO of Oracle see Image 2 below), I invite you to read about what immune cell types increase versus decrease cancer risks on pages 33-35.
IMAGE 2: Larry Ellison CEO of Oracle giddy with excitement on his announcement on January 21, 2025 at the Whitehouse to use some of the $500 billion for the STARGATE ‘artificial intelligence’ initiative to custom derive personalized cancer mRNA gene therapy shots (based on adaptive immunity recognition of the neoantigens of mutated cancer antigens) to cure cancers.
And for those among us that believe mRNA gene therapy shots can be safe and effective for any purpose, I welcome readers to examine the section on beneficial (protector HERV-K102 shedding from the upper respiratory tract to mediate herd immunity) versus harmful shedding (of the spike mRNA gene therapy compromised HERV-K102 particles) on pages 13-19 (see below Image 3 for an illustration of how this might be accomplished). See Image 4 for a summary of the shedding death counts in England from January 1, 2021 to May 31, 2022 which caused the vast majority of excess deaths during this period.
Image 3. How HERV-K102 Protector Particles Become Bioweaponized Exosomes in the URT Following the Second Dose of the Spike mRNA Gene Therapy Shots.
The ‘dirty’ lipid nanoparticles (LNPs) are covered in spike protein from the use of E. coli to produce the spike mRNA (but not the clean ones used for the clinical trials obtained by PCR). These LNPs would be targeted to the foamy macrophages in the tissues and sebocytes in the mucosa (specialized foamy macrophages in the sebaceous glands that line the mucosa such as the upper respiratory tract (URT)) after the second dose. This happens through the FCGR2A receptors on foamy macrophages/sebocytes for the FC of the spike antibodies induced by the second dose. Sadly the transfection compromises the protector HERV-K102 particles released by lysis in that they become coated in spike protein and IgG1 and IgG3 antibodies. This COMPLEX can initiate complement binding when delivered to the microcirculation deep in the lungs of the new host. This initiates clotting and microclotting which can lead to myocarditis, pulmonary embolism, sudden death, strokes etc.
[For more information: #
https://rumble.com/v51idm2-dr.-marian-laderoute-jun-01-2024-regina-saskatchewan.html ].
Image 4. The Calculated Levels of Shedding (Estimated 2 ways) Reveals Shedding Deaths were the Most Common Cause of Excess Deaths During the First 17 Months of the Pfizer Spike mRNA Gene Therapy Product Rollout (Based on Raw Death Counts) #
Of the 648,461 excess deaths during this period 498,636 were due to shedding (77%), 87,472 were due to COVID-19 (13%) and 60,917 were early vaccination induced deaths (<21 days) (9%). For the latter, some were due to direct inadvertent injection into the bloodstream, some were due to the vaccine toxicity, some involved SARS-CoV-2 infection caught at the large indoor clinics especially after the first dose, and some especially the third dose may have been due to shedding from the vaccinator (who would have been freshly immunized/injected and possibly shedding for 3 to 4 months).
I think it is instructive to remember that ‘phoney intelligence’ is only as good as the programmer.
Elon Musk, on the other hand, appears to have found a really good use for AI, auditing the federal government spending.
;-)